We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-0.25%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
-$6.3M
(-2.8%)
Cap. Flow
+$7.95M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
11.93%
Holding
763
New
327
Increased
77
Reduced
54
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.61M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.35M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$2.15M |
| 4 |
Teck Resources
TECK
|
+$2.12M |
| 5 |
BlackRock Health Sciences Trust II
BMEZ
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$3.72M |
| 2 |
Cintas
CTAS
|
+$3.03M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
+$2.87M |
| 4 |
Verizon
VZ
|
+$2.3M |
| 5 |
Veeva Systems
VEEV
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.88% |
| 2 | Financials | 13.01% |
| 3 | Technology | 12.25% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
PUT
Northern Oil and Gas
NOG
$2.56B
| $90.7K | 0.04% |
+3,000
| New | +$103K |
|
427
Bausch Health
BHC
$2.37B
| $86.7K | 0.04% |
+13,399
| New | +$96.3K |
|
428
Myomo
MYO
$56.6M
| $86.7K | 0.04% |
+18,023
| New | +$103K |
|
429
Quanterix
QTRX
$114M
| $85.5K | 0.04% |
+13,127
| New | +$110K |
|
430
Oxford Square Capital
OXSQ
$152M
| $85.3K | 0.04% |
32,667
-27,745
| -46% | -$74.7K |
|
431
FreightCar America
RAIL
$259M
| $84.9K | 0.04% |
+15,354
| New | +$146K |
|
432
Rocket Pharmaceuticals
RCKT
$397M
| $82.1K | 0.04% |
+12,309
| New | +$122K |
|
433
Real Brokerage
REAX
$466M
| $79.6K | 0.04% |
19,598
+8,856
| +82% | +$42K |
|
|
SSBK
434
DELISTED
Southern States Bancshares
SSBK
| $78.5K | 0.04% |
+2,196
| New | +$71.7K |
|
435
Xeris Biopharma Holdings
XERS
$1.46B
| $76.3K | 0.03% |
+13,901
| New | +$56.1K |
|
436
Designer Brands
DBI
$334M
| $76.3K | 0.03% |
+20,897
| New | +$98.2K |
|
437
Nkarta
NKTX
$176M
| $76.1K | 0.03% |
+41,353
| New | +$84.8K |
|
|
EWCZ
438
DELISTED
European Wax Center
EWCZ
| $74.6K | 0.03% |
18,885
+5,752
| +44% | +$34.3K |
|
439
SelectQuote
SLQT
$123M
| $74.4K | 0.03% |
+22,275
| New | +$94.5K |
|
|
HOUS
440
DELISTED
Anywhere Real Estate
HOUS
| $73.5K | 0.03% |
+22,069
| New | +$78.2K |
|
|
HIVE
441
HIVE Digital Technologies
HIVE
$711M
| $73.2K | 0.03% |
50,474
-20,181
| -29% | -$49.7K |
|
442
PUT
DraftKings
DKNG
$12B
| $69.7K | 0.03% |
+2,100
| New | +$86.3K |
|
443
Unisys
UIS
$211M
| $69.2K | 0.03% |
15,071
-1,704
| -10% | -$9.5K |
|
444
Bumble
BMBL
$360M
| $67.9K | 0.03% |
+15,651
| New | +$102K |
|
|
CRGX
445
DELISTED
CARGO Therapeutics
CRGX
| $67.9K | 0.03% |
+16,680
| New | +$112K |
|
446
Atea Pharmaceuticals
AVIR
$402M
| $66.4K | 0.03% |
+22,202
| New | +$69.3K |
|
447
Aclaris Therapeutics
ACRS
$867M
| $63.8K | 0.03% |
+41,723
| New | +$89K |
|
448
AbCellera Biologics
ABCL
$2.85B
| $63K | 0.03% |
+28,241
| New | +$81K |
|
|
ONTF
449
DELISTED
ON24
ONTF
| $62.4K | 0.03% |
+12,002
| New | +$74.4K |
|
450
Pliant Therapeutics
PLRX
$64.4M
| $62.1K | 0.03% |
+45,965
| New | +$279K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Oxford Asset Management held 763 positions worth $219M, down 2.8% from $225M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Oxford Asset Management deployed $7.95M of net new capital in Q1 2025, opening 327 new positions and adding to 77 existing holdings. Its largest new stake was Oracle: 16,001 shares worth $2.24M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Cintas, an estimated $3.03M trimmed.
- Oxford Asset Management's largest Q1 2025 buy was Oracle: 16,001 shares worth $2.24M.
- Oxford Asset Management added most to NEVRO CORP. in Q1 2025, an estimated $2.05M increase.
- Oxford Asset Management's biggest Q1 2025 reduction was Cintas, cutting an estimated $3.03M.
- Oxford Asset Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $3.72M.
- Oxford Asset Management's ten largest holdings make up 12% of its $219M portfolio in Q1 2025.
- Oxford Asset Management opened 327 new positions and closed 297 in Q1 2025.
- Oxford Asset Management's portfolio value fell 2.8% quarter-over-quarter to $219M.
Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.